Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2015

01-06-2015 | Original Article

Alpha-Thalassemia Mutations in Adana Province, Southern Turkey: Genotype-Phenotype Correlation

Authors: Sevcan Tug Bozdogan, Ozge Ozalp Yuregir, Nurhilal Buyukkurt, Huseyin Aslan, Zeynep Canan Ozdemir, Tomasz Gambin

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2015

Login to get access

Abstract

To look over the distribution of the mutations in a large series from Adana province, Southern Turkey, and determine the genotype-phenotype correlation of the frequent mutations. Among the 2500 individuals with mild or moderate anemia, microcytosis, and normal iron levels that were referred to our Genetic Diagnosis Center, a population consisting of 539 individuals were included in the study and tested for alpha-thalassemia mutations by using reverse dot blot hybridization technique. Twelve different mutations were detected in 539 patients. Among the 12 different mutations found, the most frequent mutations were the –α3.7 (63.3 %), --MED (11.7 %), --20.5 (10.7 %), α2IVS1(−5nt) (3.9 %), and α2polyA−2 (3.5 %). The most frequent genotypes were –α3.7/αα (35.8 %), –α3.7/-α3.7(18.9 %), –20.5/αα (11.5 %), and --MED/αα (10.4 %), respectively. There were statistically significant differences in hematological findings between –α3.7/–α3.7 and --MED/αα, even though both have two mutated genes in the genotype. Our results show that alpha-thalassemia mutations are highly heterogeneous as well as deletional and –α3.7 single gene deletion is particularly prevalent at Adana province in agreement to other studies from Turkey.
Literature
1.
go back to reference Kan YW, Golbus MS, Dozy AM (1976) Prenatal diagnosis of alpha-thalassemia. Clinical application of molecular hybridization. N Engl J Med 295:1165–1167CrossRefPubMed Kan YW, Golbus MS, Dozy AM (1976) Prenatal diagnosis of alpha-thalassemia. Clinical application of molecular hybridization. N Engl J Med 295:1165–1167CrossRefPubMed
2.
go back to reference Celik MM, Gunesacar R, Oktay G, Duran GG, Kaya H (2013) Spectrum of α-thalassemia mutations including first observation of—(FIL) deletion in Hatay Province Turkey. Blood Cells Mol Dis 51:27–30CrossRefPubMed Celik MM, Gunesacar R, Oktay G, Duran GG, Kaya H (2013) Spectrum of α-thalassemia mutations including first observation of—(FIL) deletion in Hatay Province Turkey. Blood Cells Mol Dis 51:27–30CrossRefPubMed
3.
go back to reference Sengchanh S, Sanguansermsri T, Horst D, Horst J, Flatz G (2005) High frequency of alphathalassemia in the So ethnic group of South Laos. Acta Haematol 114:164–166CrossRefPubMed Sengchanh S, Sanguansermsri T, Horst D, Horst J, Flatz G (2005) High frequency of alphathalassemia in the So ethnic group of South Laos. Acta Haematol 114:164–166CrossRefPubMed
4.
go back to reference Higgs DR, Vickers MA, Wilkie AOM, Pretorius I-M, Jarman AP, Weatherall DJ (1989) A review of the molecular genetics of the human a-globin gene cluster. Blood 73:1081–1104PubMed Higgs DR, Vickers MA, Wilkie AOM, Pretorius I-M, Jarman AP, Weatherall DJ (1989) A review of the molecular genetics of the human a-globin gene cluster. Blood 73:1081–1104PubMed
5.
go back to reference Puehringer H, Najmabadi H, Law HY, Walter Krugluger W, Viprakasit V, Serge Pissard S, Baysal E, Taher A, Farra C, Al-Ali A, Al-Ateeq S, Oberkanins C (2007) Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common a-thalassemia point mutations and deletions. Clin Chem Lab Med 45:605–610CrossRefPubMed Puehringer H, Najmabadi H, Law HY, Walter Krugluger W, Viprakasit V, Serge Pissard S, Baysal E, Taher A, Farra C, Al-Ali A, Al-Ateeq S, Oberkanins C (2007) Validation of a reverse-hybridization StripAssay for the simultaneous analysis of common a-thalassemia point mutations and deletions. Clin Chem Lab Med 45:605–610CrossRefPubMed
6.
go back to reference Al-Allawi NA, Badi AI, Imanian H, Nikzat N, Jubrael JM, Najmabadi H (2009) Molecular characterization of alpha-thalassemia in the Dohuk region of Iraq. Hemoglobin 33:37–44CrossRefPubMed Al-Allawi NA, Badi AI, Imanian H, Nikzat N, Jubrael JM, Najmabadi H (2009) Molecular characterization of alpha-thalassemia in the Dohuk region of Iraq. Hemoglobin 33:37–44CrossRefPubMed
7.
8.
go back to reference Zandian K, Nateghi J, Keikhaie B, Pedram M, Hafezi-Nejad N, Hadavi V, Oberkanins C, Azarkeivan A, Law HY, Najmabadi H (2008) a-Thalassemia mutations in Khuzestan Province Southwest Iran. Hemoglobin 32:546–552CrossRefPubMed Zandian K, Nateghi J, Keikhaie B, Pedram M, Hafezi-Nejad N, Hadavi V, Oberkanins C, Azarkeivan A, Law HY, Najmabadi H (2008) a-Thalassemia mutations in Khuzestan Province Southwest Iran. Hemoglobin 32:546–552CrossRefPubMed
10.
go back to reference Oner C, Gürgey A, Oner R, Balkan H, Gümrük F, Baysal E, Altay C (1997) The molecular basis of Hb H disease in Turkey. Hemoglobin 21:41–51CrossRefPubMed Oner C, Gürgey A, Oner R, Balkan H, Gümrük F, Baysal E, Altay C (1997) The molecular basis of Hb H disease in Turkey. Hemoglobin 21:41–51CrossRefPubMed
11.
12.
go back to reference Guvenc B, Yildiz SM, Tekinturhan F, Dincer S, Akyuzluer I, Okten S, Erkman H (2010) Molecular characterization of alpha-Thalassemia in Adana, Turkey: a single center study. Acta Haematol 123:197–200CrossRefPubMed Guvenc B, Yildiz SM, Tekinturhan F, Dincer S, Akyuzluer I, Okten S, Erkman H (2010) Molecular characterization of alpha-Thalassemia in Adana, Turkey: a single center study. Acta Haematol 123:197–200CrossRefPubMed
13.
go back to reference Sutcu R, Aylak F, Kocak H, Sipahi T, Vural H, Delibas N (2011) The investigation of distribution of hereditary alpha-thalassemia mutations in Isparta reservoir. Eur J Basic Med Sci 1:28–32 Sutcu R, Aylak F, Kocak H, Sipahi T, Vural H, Delibas N (2011) The investigation of distribution of hereditary alpha-thalassemia mutations in Isparta reservoir. Eur J Basic Med Sci 1:28–32
14.
go back to reference Zandian K, Nateghi J, Keikhaie B, Pedram M, Hafezi-Nejad N, Hadavi V, Oberkanins C, Azarkeivan A, Law HY, Najmabadi H (2008) alpha-thalassemia mutations in Khuzestan Province Southwest Iran. Hemoglobin 32:546–552CrossRefPubMed Zandian K, Nateghi J, Keikhaie B, Pedram M, Hafezi-Nejad N, Hadavi V, Oberkanins C, Azarkeivan A, Law HY, Najmabadi H (2008) alpha-thalassemia mutations in Khuzestan Province Southwest Iran. Hemoglobin 32:546–552CrossRefPubMed
15.
go back to reference Hellani A, Fadel E, El-Sadadi S, El-Sweilam H, El-Dawood A, Abu-Amero KK (2009) Molecular spectrum of alpha-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Mol Biomarkers 13:219–221CrossRefPubMed Hellani A, Fadel E, El-Sadadi S, El-Sweilam H, El-Dawood A, Abu-Amero KK (2009) Molecular spectrum of alpha-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Mol Biomarkers 13:219–221CrossRefPubMed
16.
go back to reference Abu Ghoush MW (2008) Subtypes of alpha thalassemia diagnosed at a Medical Center in Jordan. TAF Prev Med Bull 7:373–376 Abu Ghoush MW (2008) Subtypes of alpha thalassemia diagnosed at a Medical Center in Jordan. TAF Prev Med Bull 7:373–376
17.
go back to reference El-Kalla S, Baysal E (1998) alpha-Thalassemia in the United Arab Emirates. Acta Haematol 100:49–53CrossRefPubMed El-Kalla S, Baysal E (1998) alpha-Thalassemia in the United Arab Emirates. Acta Haematol 100:49–53CrossRefPubMed
18.
go back to reference Hassan SM, Hamza N, Jaffer Al-Lawatiya F, Jaffer Mohammed A, Harteveld CL, Rajab A, Giordano PC (2010) Extended molecular spectrum of beta- and alpha-thalassemia in Oman. Hemoglobin 34:127–134CrossRefPubMed Hassan SM, Hamza N, Jaffer Al-Lawatiya F, Jaffer Mohammed A, Harteveld CL, Rajab A, Giordano PC (2010) Extended molecular spectrum of beta- and alpha-thalassemia in Oman. Hemoglobin 34:127–134CrossRefPubMed
19.
go back to reference Siala H, Ouali F, Messaoud T, Bibi A, Fattoum S (2008) alpha-Thalassaemia in Tunisia: some epidemiological and molecular data. J Genet 87:229–234CrossRefPubMed Siala H, Ouali F, Messaoud T, Bibi A, Fattoum S (2008) alpha-Thalassaemia in Tunisia: some epidemiological and molecular data. J Genet 87:229–234CrossRefPubMed
20.
go back to reference Oron-Karni V, Filon D, Shifrin Y, Fried E, Pogrebijsky G, Oppenheim A, Rund D (2000) Diversity of alpha-globin mutations and clinical presentation of alpha-thalassemia in Israel. Am J Hematol 65:196–203CrossRefPubMed Oron-Karni V, Filon D, Shifrin Y, Fried E, Pogrebijsky G, Oppenheim A, Rund D (2000) Diversity of alpha-globin mutations and clinical presentation of alpha-thalassemia in Israel. Am J Hematol 65:196–203CrossRefPubMed
21.
go back to reference Di Bella C, Salpietro C, La Rosa M, Cuppari C, Piraino B, Cutri MR, Rigoli L (2006) Identification of alpha-thalassemia mutations in subjects from Eastern Sicily (Italy) with abnormal hematological indices and normal Hb A2. Ann Hematol 85:829–831CrossRefPubMed Di Bella C, Salpietro C, La Rosa M, Cuppari C, Piraino B, Cutri MR, Rigoli L (2006) Identification of alpha-thalassemia mutations in subjects from Eastern Sicily (Italy) with abnormal hematological indices and normal Hb A2. Ann Hematol 85:829–831CrossRefPubMed
22.
go back to reference Souza AE, Cardoso GL, Takanashi SY, Guerreiro JF (2009) Alpha-thalassemia (3.7 kb deletion) in a population from the Brazilian Amazon region: santarém, Pará State. Genet Mol Res 8:477–481CrossRefPubMed Souza AE, Cardoso GL, Takanashi SY, Guerreiro JF (2009) Alpha-thalassemia (3.7 kb deletion) in a population from the Brazilian Amazon region: santarém, Pará State. Genet Mol Res 8:477–481CrossRefPubMed
23.
go back to reference Moosavi SF, Amirian A, Zarbakhsh B, Kordafshari A, Mirzahoseini H, Zeinali S, Karimipoor M (2011) The carrıer frequency of α-globin gene triplication in an Iranian populatıon with normal or borderline hematological parameters. Hemoglobin 35(4):323–330CrossRefPubMed Moosavi SF, Amirian A, Zarbakhsh B, Kordafshari A, Mirzahoseini H, Zeinali S, Karimipoor M (2011) The carrıer frequency of α-globin gene triplication in an Iranian populatıon with normal or borderline hematological parameters. Hemoglobin 35(4):323–330CrossRefPubMed
24.
go back to reference Baysal E, Kleanthous M, Bozkurt G, Kyrri A, Kalogirou E, Angastiniotis M, Ioannou P, Huisman TH (1995) alpha-Thalassaemia in the population of Cyprus. Br J Haematol 89:469–496CrossRef Baysal E, Kleanthous M, Bozkurt G, Kyrri A, Kalogirou E, Angastiniotis M, Ioannou P, Huisman TH (1995) alpha-Thalassaemia in the population of Cyprus. Br J Haematol 89:469–496CrossRef
25.
go back to reference Laig M, Pape M, Hundrieser J, Flatz G, Sanguansermsri T, Das BM, Deka R, Yongvanit P, Mularlee N (1990) The distribution of the Hb constant spring gene in Southeast Asian populations. Hum Genet 84:188–190CrossRefPubMed Laig M, Pape M, Hundrieser J, Flatz G, Sanguansermsri T, Das BM, Deka R, Yongvanit P, Mularlee N (1990) The distribution of the Hb constant spring gene in Southeast Asian populations. Hum Genet 84:188–190CrossRefPubMed
26.
go back to reference Clegg JB, Weatherall DJ, Milner PF (1971) Haemoglobin Constant Spring–a chain termination mutant? Nature 234:337–340CrossRefPubMed Clegg JB, Weatherall DJ, Milner PF (1971) Haemoglobin Constant Spring–a chain termination mutant? Nature 234:337–340CrossRefPubMed
27.
go back to reference Xiong F, Sun M, Zhang X, Cai R, Zhou Y, Lou J, Zeng L, Sun Q, Xiao Q, Shanq X, Wei X, Zhanq T, Chen P, Xu X (2010) Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet 78:139–148CrossRefPubMed Xiong F, Sun M, Zhang X, Cai R, Zhou Y, Lou J, Zeng L, Sun Q, Xiao Q, Shanq X, Wei X, Zhanq T, Chen P, Xu X (2010) Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of southern China. Clin Genet 78:139–148CrossRefPubMed
28.
go back to reference Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, Lu JP, Jia SQ, Xiao GF, Shen X, Li J, Chen HP, Xia YY, Wen YX, Mo QH, Li WD, Li YY, Zhuo LW, Wanq ZQ, Chen YJ, Qin CH, Zhonq M (2004) The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 57:517–522CrossRefPubMedCentralPubMed Xu XM, Zhou YQ, Luo GX, Liao C, Zhou M, Chen PY, Lu JP, Jia SQ, Xiao GF, Shen X, Li J, Chen HP, Xia YY, Wen YX, Mo QH, Li WD, Li YY, Zhuo LW, Wanq ZQ, Chen YJ, Qin CH, Zhonq M (2004) The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 57:517–522CrossRefPubMedCentralPubMed
30.
go back to reference Rahim F (2009) Microcytic hypochromic anemia patients with thalassemia: genotyping approach. Indian J Med Sci 63:101–108CrossRefPubMed Rahim F (2009) Microcytic hypochromic anemia patients with thalassemia: genotyping approach. Indian J Med Sci 63:101–108CrossRefPubMed
31.
go back to reference Di Marzo R, Lo Gioco P, Giambona A, Acuto S, Sammarco P, Oddo G, Maggio A (1986) Clinical severity of non-deletion form of HbH disease (--Med/alpha alpha thal). Scand J Haematol 36:39–43CrossRefPubMed Di Marzo R, Lo Gioco P, Giambona A, Acuto S, Sammarco P, Oddo G, Maggio A (1986) Clinical severity of non-deletion form of HbH disease (--Med/alpha alpha thal). Scand J Haematol 36:39–43CrossRefPubMed
Metadata
Title
Alpha-Thalassemia Mutations in Adana Province, Southern Turkey: Genotype-Phenotype Correlation
Authors
Sevcan Tug Bozdogan
Ozge Ozalp Yuregir
Nurhilal Buyukkurt
Huseyin Aslan
Zeynep Canan Ozdemir
Tomasz Gambin
Publication date
01-06-2015
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2015
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-014-0406-0

Other articles of this Issue 2/2015

Indian Journal of Hematology and Blood Transfusion 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine